Astrazeneca AZN Earnings Call Transcripts

NYSE AZN
$174.51 +4.97 (+2.93%)
At close: Oct 29, 2026 · 4:00 PM EDT
15 earnings calls on file for Astrazeneca, from Q4 2019 to Q4 2024. Each transcript opens in a new tab.
Latest earnings call

Astrazeneca Q4 2024 Earnings Call

Feb 6, 2025 15,949 words · 69 min read
  • Pascal SoriotExecutive Director and Chief Executive Officer
  • Iskra ReicExecutive Vice President, International
  • Aradhana SarinExecutive Director and Chief Financial Officer
  • David FredricksonExecutive Vice President, Oncology Business
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Astrazeneca Earnings Call Transcripts

Calls15
LatestFeb 6, 2025
SinceQ4 2019

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2020

Fiscal 2019

All 15 Astrazeneca transcripts Register to get access to Astrazeneca’s earnings call transcripts.